ALPHATON CAPITAL CORP (ATON) Stock Price & Overview
NASDAQ:ATON • VGG7185A1369
The current stock price of ATON is 0.3926 USD. Today ATON is down by -1.97%. In the past month the price decreased by -21.78%.
ATON Key Statistics
- Market Cap
- 9.199M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -5.72
- Dividend Yield
- N/A
ATON Stock Performance
ATON Stock Chart
ATON Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ATON.
ATON Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ATON. While ATON seems to be doing ok healthwise, there are quite some concerns on its profitability.
ATON Earnings
ATON Forecast & Estimates
ATON Groups
Sector & Classification
ATON Financial Highlights
Over the last trailing twelve months ATON reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 92.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.12% | ||
| ROE | -70.59% | ||
| Debt/Equity | 0 |
ATON Ownership
ATON Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.28 | 401.392B | ||
| AMGN | AMGEN INC | 16.52 | 202.383B | ||
| GILD | GILEAD SCIENCES INC | 16.69 | 184.425B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.5 | 126.804B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.68 | 81.619B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.75 | 42.754B | ||
| INSM | INSMED INC | N/A | 31.007B | ||
| NTRA | NATERA INC | N/A | 28.197B | ||
| BIIB | BIOGEN INC | 11.87 | 27.651B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.05 | 23.485B | ||
| MRNA | MODERNA INC | N/A | 21.714B | ||
| EXAS | EXACT SCIENCES CORP | 340 | 19.732B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.591B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ATON
Company Profile
AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The firm implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. The company is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The firm engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.
Company Info
IPO: 2013-10-28
ALPHATON CAPITAL CORP
Clarence Thomas Building, P.O. Box 4649, Road Town
Tortola ONTARIO VG
Employees: 3
Phone: 4167377600
ALPHATON CAPITAL CORP / ATON FAQ
What does ATON do?
AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The firm implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. The company is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The firm engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.
What is the stock price of ALPHATON CAPITAL CORP today?
The current stock price of ATON is 0.3926 USD. The price decreased by -1.97% in the last trading session.
Does ATON stock pay dividends?
ATON does not pay a dividend.
What is the ChartMill technical and fundamental rating of ATON stock?
ATON has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for ALPHATON CAPITAL CORP?
ALPHATON CAPITAL CORP (ATON) currently has 3 employees.
Can you provide the market cap for ALPHATON CAPITAL CORP?
ALPHATON CAPITAL CORP (ATON) has a market capitalization of 9.20M USD. This makes ATON a Nano Cap stock.